Jobs, make money,home business,freelance jobs,telecommute, Interview,
Resume, Career
BiodefenseStocks Reports on Today’s Technology and Count
BiodefenseStocks Reports on Today’s Technology and Countermeasures
Working to Defend against Biowarfare and Bioterrorism
Homeland Security Department Elevates Bioterrorism to Higher Level of
Priority
POINT ROBERTS, WA.; July 20, 2005 – BiodefenseStocks (BS), and
HomelandDefenseStocks (HDS), investor news portals for the Biodefense and
Homeland Security sectors, report on today’s technology and
countermeasures working to defend against threats of bioterrorism through
an exclusive article – “Countermeasures against Bioterrorism and
Biowarfare – Are We Prepared?” Companies participating in the nation’s
biodefense efforts include CryoPort (OTC.PK: CYRX), a manufacturer of a
disposable cryogenic shipper for infectious materials; Hollis-Eden
Pharmaceuticals, Inc. (NASDAQ: HEPH), developer of the drug Neumune™ for
treatment of Acute Radiation Syndrome (ARS); Aethlon Medical (OTCBB:
AEMD), a developer of viral filtration devices that rapidly reduce the
presence of infectious disease and toxins in the body; Roaming Messenger
(OTCBB: RMSG) an interactive messaging solution provider that enables the
delivery of critical information; and MDM Group (OTC.PK: MDDM), a
developer of vaccines and screening solutions through their Biodefense
Division.
BiodefenseStocks and HomelandDefenseStocks are investor and industry news
portals for the biodefense and homeland security sector. The BS and HDS
websites do not make recommendations, but offer unique free information
portals to research news, exclusive articles, interviews, investor
conferences and a growing list of participating public companies in these
sectors.
Report Excerpt: Countermeasures against Bioterrorism and Biowarfare – Are
We Prepared?
By Ann-Marie Fleming, BiodefenseStocks and HomelandDefenseStocks
July 2005
As the Homeland Security Department increases the priority level placed
on bioterrorism, and the government pushes forward in the development of
Project BioShield, the necessity for evolved and adaptive technology and
methods to prevent and resolve such threats, becomes a major focus for
National Security and the industry at large.
Security Secretary Michael Chertoff recently presented the results of the
Department of Homeland Security’s Second Stage Review, which consists of
an evaluation of the Department’s operations, policies and structures.
Subsequent to the release of the results of this review, a renewed sense
of priority regarding the nation’s ability to detect biological attacks
became apparent. As Chertoff states, “we must also prepare for terror
attacks of even greater consequence — attacking transit systems with
biological, radiological or chemical agents. We now have in place a
network of bio-sensors, but we will accelerate the development and
deployment of the next generation technology in bio-sensors to more
quickly detect biological, radiological, and chemical attacks.”
According to a report by Civitas Group, “In terms of the severity of
consequences, the threat of a terrorist attack against the homeland
involving a nuclear or biological weapon is the most worrisome scenario
facing the United States today.” With that said, the report revealed that
the biological sensor market is still fairly undeveloped, but is
experiencing significant forward progression as a result of the
government’s focus on such technology and biological threats. According
to Mark Shaheen, a Principal at the Civitas Group, “The Second Stage
Review indicates the intention of the Department to take a more
significant role in biodefense, as evidenced by Chertoff’s creation of a
Chief Medical Officer who will be a direct, more senior official with
responsibility for biodefense issues at the department; this is a
positive sign.”
Government programs such as Project Bioshield that was implemented to
help spark participation in biodefense from the private sector, and in
particular from biotechnology and pharmaceutical companies, has further
emphasized the prioritization of the threat level associated with
bioterrorism. However, Mr. Shaheen explains, while there is significant
market potential for biosensors, the impact of BioShield is yet to be
fully determined.
To Read the Full Report Click Here: BiodefenseStocks
/BDS/News/Bioterror_Defense.asp
Participating Public Companies:
Hollis-Eden Pharmaceuticals, Inc. (NASDAQ: HEPH), Aethlon Medical (OTCBB:
AEMD), MDM Group (OTC.PK: MDDM), CryoPort (OTC.PK: CYRX), Roaming
Messenger (OTCBB: RMSG)
(HDS and BS are compensated for Featured companies on portals – see
disclaimer for details)
BiodefenseStocks includes public companies in the sector and industry
information on Bioterrorism, Agriterrorism, Vaccines, Countermeasures to
Bioterrorism, Biological & Chemical Detection, Emergency Response and
Preparedness, Biological, Chemical, and Radiological News.
For a partial list of companies involved in Biodefense Click Here:
biodefensestocks /BDS/Stock_List.asp
HomelandDefenseStocks includes a growing list of public companies in the
sector. Click here for a partial list of companies involved in homeland
defense and security technology and solutions in Airport Security,
Biodefense, Biometrics, Defense, Internet Security, Integrated Security,
Military, Border and Port Security.
HomelandDefenseStocks /Companies/HomelandDefense/Stock_List.asp
Additional HDS Homeland Security Web Sites:
NationalHomelandSecurityKnowledgebase : including comprehensive Homeland
Security information resources, Homeland Security news, Homeland Security
marketplace, directories and a collection of links on Homeland Security
related topics.
BorderAndPortSecurity
NonlethalStocks
The Insiders Corner with Michael Brush
Read the exclusive InvestorIdeas Feature “The Insiders Corner,” a weekly
feature by well-known financial writer and author Michael Brush.
investorideas /insiderscorner/
Investor Incite Newsletter
InvestorIdeas free “Investor Incite” Newsletter consists of company and
industry updates, investment research and developing trends in key areas
such as Homeland Security, Renewable Energy, Nanotechnology and more.
TO SIGN UP, click here: InvestorIdeas /Resources/Newsletter.asp
Disclaimer: ECON Investor Relations Inc is the owner of the domains
BiodefenseStocks and HomelandDefenseStocks . Our site does not make
recommendations, but offers a unique information portal to investors to
research news, articles, and recent research. Nothing on our sites should
be construed as an offer or solicitation to buy or sell any specific
products or securities. All investments involve risk. Although we attempt
to research thoroughly, we offer no guarantees as to the accuracy of any
information presented. We encourage all investors to use our sites only
as a resource to further their own research. All information relating to
featured companies is sourced from public documents and/ or the company
and is not the opinion of ECON or its related web sites. The site is
currently compensated for by its “featured companies.” CryoPort, Inc.:
Five Thousand Dollars per month. Aethlon Medical, Inc.: Three Thousand
Dollars per month plus restricted shares equivalent to Five Thousand
Dollars per month. MDM Group, Inc. pay an amount equal to approximately
thirteen thousand five hundred. MDM Group Inc. shares per month for
consulting services provide for both MDM Group Inc. and its subsidiary,
Harrington Group Ltd. (HGR). Roaming Messenger, Inc. (OTCBB: RMSG) Three
thousand dollars per month, plus three thousand dollars per month
equivalent in shares. Featured Companies on HDS / BS current list of
stocks. InvestorIdeas /About/Disclaimer.asp
Contact:
Dawn Van Zant / Trevor Ruehs
Toll free: 800-665-0411
Email: dvanzant@HomelandDefenseStocks , truehs@HomelandDefenseStocks
About the author:
BiodefenseStocks and HomelandDefenseStocks are investor and industry news
portals for the biodefense and homeland security sector. The BS and HDS
websites do not make recommendations, but offer unique free information
portals to research news, exclusive articles, interviews, investor
conferences and a growing list of participating public companies in these
sectors.
* |